Max Financial Services (MFSL) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
9 Jan, 2026Executive summary
Completed rebranding to Axis Max Life Insurance, leveraging combined brand strength for deeper penetration in Tier 2 and Tier 3 cities and sustaining long-term growth strategies.
Individual adjusted first-year premium rose 25%, outpacing private sector (19%) and industry (14%), with private market share expanding to 9.3% from 8.9% year-over-year.
Product innovation and digital transformation initiatives improved operational efficiency, customer satisfaction, and risk management.
Recognized for business excellence, customer service, and as a top workplace.
Board approved unaudited results for the quarter and nine months ended December 31, 2024, with no material misstatements identified by auditors.
Financial highlights
Consolidated revenue (excluding investment income) grew 14% to ₹20,907 crore for nine months FY 2025; Q3 FY25 revenue was ₹8,923.21 crore.
Consolidated profit after tax reached ₹365 crore for nine months; Q3 FY25 net profit was ₹69.81 crore.
Gross premium increased 14% to ₹21,360 crore; renewal premium up 12% to ₹13,269 crore.
Value of new business (VNB) grew 9% to ₹1,255 crore, with a new business margin (NBM) of 21.9%.
Assets under management rose 20% to ₹1.72 lakh crore.
Outlook and guidance
Targeting close to 20% sales growth and high single-digit VNB growth for FY 2025.
Aiming to maintain VNB margins around 25% as product mix is rebalanced.
Focus on sustainable growth, proprietary channel expansion, and digital transformation.
Persistency and customer experience remain key priorities, with NPS improving to 61 in Q3 FY'25.
Latest events from Max Financial Services
- Consolidated profit included a Rs 427.63 crore Hutchison Essar disposal gain.MFSL
Q4 05/06 - Post-merger profit reached Rs. 180.62 lakhs as expansion plans met execution and licensing risks.MFSL
Q4 92/93 - FY95 profit rose as business units expanded and telecom ventures launched, alongside sizable commitments and exposures.MFSL
Q4 94/95 - FY94 profit reached Rs 775.53 lakh as pharma and BOPP growth strengthened operations.MFSL
Q4 93/94 - Revenue rose as investment-backed expansion broadened the business portfolio.MFSL
Q4 95/96 - Combined business volume grew, but lower profit and market pressures tempered FY97.MFSL
Q4 96/97 - Service-sector expansion advanced as lower investment income sharply reduced parent-level profit.MFSL
Q4 00/01 - Rs 37.20 crore PAT backed a pivot to healthcare, insurance and IT.MFSL
Q4 99/00 - A one-time telecom dividend lifted earnings as operating units improved and growth plans shifted to services.MFSL
Q4 98/99 - Telecom divestment strengthened finances as restructuring reshaped the portfolio.MFSL
Q4 97/98